Gastrointestinal Complications in Liver Transplant Recipients: MITOS Study

Transplantation Proceedings

Volumn 39, Issue 7, 2007, Pages 2311-2313

  Herrero, J I ^a   Benlloch, S ^b   Bernardos, A ^c   Bilbao, I ^b   Castells, L ^b   Castroagudin, J F ^d   Gonzalez L ^e   Irastorza, I ^b   Navasa, M ^f   Otero, A ^b   Pons, J A ^b   Rimola, A ^f   Suarez F ^b   Casanovas, T ^b   Otero, E ^d   Rodriguez M ^e   Serrano, T ^g   Otero, S ^b   Lopez I ^b   Miras, M ^b   Prieto, M ^b   more..

^a Unidad Coronaria   (Spain)

^b H La Fe ^*  (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^d Instituto de Salud Carlos III   (Spain)

^e Hospital Central Asturias   (Spain)

^f Oviedo   (Spain)

^g HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS;

ABDOMINAL PAIN; ADULT; ANOREXIA; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DIARRHEA; DIGESTIVE SYSTEM PERFORATION; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; DYSPEPSIA; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL REFLUX; GRAFT RECIPIENT; HEARTBURN; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER GRAFT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; NAUSEA; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; VOMITING;

ADULT; AGED; CADAVER; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; FEMALE; GASTROINTESTINAL DISEASES; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INPATIENTS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREVALENCE; SPAIN; TISSUE DONORS;

EID: 34548731329     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.06.012     Document Type: Article

References (10)

1. Helderman J.H., and Goral S. Gastrointestinal complications of transplant immunosuppression. Review. J Am Nephrol 13 (2002) 277
2. Rubin R.H. Gastrointestinal infectious disease complications following transplantation and their differentiation from immunosuppresant-induced gastrointestinal toxicities. Clin Transplant 15 suppl 4 (2001) 11
3. Hardinger K.L., Brennan D.C., Lowel J., et al. Long term outcome of gastrointestinal complications in renal transplant patients treated with MMF mofetil. Clin Transplant Int 17 (2004) 609
4. Helderman J.H. Prophylaxis and treatment og gastrointestinal complications after transplantation. Clin Transplant 15 suppl 4 (2001) 29
5. Tierce J.C., Porterfield-Baxa J., Petrilla A.A., et al. Impact of mycophenolate mofetil(MMF) related gastrointestinal complications and MMF dose alterations on transplant outcomes and health care costs in renal transplant recipients. Clin Transplant 19 (2005) 779
6. Caraceni P., Fagiuoli S., Wright H.L., et al. Gastrointestinal complications of liver transplantation. Ital J Gastroenterol 27 (1995) 29
7. Ginsburg P.M., and Thuluvath P.J. Diarrhea in liver transplant recipients: etiology and management. Liver Transpl 11 (2005) 881
8. Wong N.A., Bathgate A.J., and Bellamy C.O. Colorectal disease in liver allograft recipients-a clinicopathological study with follow up. Eur J Gastroenterol Hepatol 14 (2002) 231
9. Bunnapradist S., Lentine K.L., Burroughs T.E., et al. Mycophenolate mofetil dose reduction and discontinuation after gastrointestinal complications are associated with renal transplant graft failure. Transplantation 82 (2006) 102
10. Dumortier J., Gagnieu M.C., Salandre J., et al. Conversion from mycophenolate mofetil to enteric coated mycophenolate sodium in liver transplant patients presenting gastrointestinal disorders: a pilot study. Liver Transpl 12 (2006) 1342